Variables | N (%) |
---|---|
Age (years) | |
Mean age at MS onset | 23 years |
Mean age at pregnancy onset | 26.6 years |
Level of education | |
High school | 21 (72.4) |
Undergraduate | 8 (27.6) |
Marital status | |
Engaged | 8 (27.6) |
Married | 21 (72.4) |
Comorbidities | |
Diabetes | 2 (6.9) |
Hypertension | 3 (10.3) |
MS lesions | |
Brain | 29 (100) |
Brain and cervical spine | 7 (24.1) |
MS diagnosis | |
MRI | 29 (100) |
CSF and oligoclonal positive | 26 (89.7) |
CSF and oligoclonal not performed | 3 (10.3) |
Pregnancies after MS onset | |
One | 4 (13.8) |
Two | 15 (51.7) |
Three | 10 (34.5) |
Supplements taken during pregnancy | |
Vitamin D3 | 21 (72.4) |
Co-enzyme Q-10 | 20 (69) |
Fluoxetine | 11 (37.9) |
Magnesium sulfate | 21 (72.4) |
Delivery method | |
Normal vaginal | 23 (79.3) |
Caesarean | 6 (20.7) |
Epidural anaesthesia | 21 (72.4) |
Length of breastfeeding (days) | |
21–35 | 6 (20.7) |
93–255 | 23 (79.3) |
Treatment after pregnancy | |
Resumed after 11–14 months | 22 (75.9) |
Stopped indefinitely | 7 (24.1) |
CSF, cerebrospinal fluid; LeMS, the Lebanese Multiple Sclerosis study; MS, multiple sclerosis.